Newsroom

Press Release - Corporate

• 09 Jan 2023
  Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based Therapeutics
• 09 Jan 2023
  Agilent Authorizes $2 Billion Share Repurchase Program
• 04 Jan 2023
  Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
• 16 Dec 2022
  Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences
• 07 Dec 2022
  Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies
• 21 Nov 2022
  Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results
• 16 Nov 2022
  Agilent Announces Cash Dividend of 22.5 Cents Per Share
• 15 Nov 2022
  Agilent to Present at the Evercore ISI HealthCONx Conference
• 01 Nov 2022
  Agilent to Announce Fourth-Quarter Fiscal Year 2022 Financial Results Nov. 21
• 11 Oct 2022
  World Economic Forum Recognizes Agilent Facility in Singapore as a Leader in Advanced Manufacturing